CeftizoximeThird Party Manufacturing in India

Ceftizoxime works by binding to and inactivating penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. PBPs are crucial enzymes responsible for cell wall synthesis during bacterial cell division.

By targeting these key enzymes, Ceftizoxime inhibits the transpeptidation step necessary for the cross-linking of peptidoglycan chains, which provides the cell wall with its structural strength. This disruption weakens the bacterial cell wall, leading to cell swelling, membrane instability, and eventual osmotic lysis and cell death.

Unlike earlier generations of cephalosporins, Ceftizoxime exhibits high stability against hydrolysis by a broad spectrum of beta-lactamase enzymes. It is highly effective for treating severe infections caused by both Gram-positive and Gram-negative aerobic and anaerobic bacteria, making it a reliable broad-spectrum therapeutic option. It is well-tolerated across diverse patient populations, including pediatric and geriatric patients, for various systemic infections.

Therapeutic Uses

Ceftizoxime is prescribed for the treatment of:

• Lower Respiratory Tract Infections: Treats severe bacterial pneumonia and bronchitis caused by susceptible strains.
• Urinary Tract Infections: Manages both complicated and uncomplicated infections of the renal system.
• Skin and Soft Tissue Infections: Resolves deep-seated dermal and subdermal bacterial infections.
• Intra-abdominal Infections: Used to treat peritonitis and pelvic inflammatory disease.
• Septicemia: Manages systemic bacterial infections in the bloodstream.

Why Partner with a WHO-GMP Ceftizoxime Manufacturer

Ceftizoxime third party manufacturing in India is a key service for pharmaceutical brands seeking high-demand injectable antibiotics. This molecule remains a cornerstone of inpatient antibiotic therapy due to its wide therapeutic index, low toxicity profile, and resistance to beta-lactamases. Because it is administered primarily via intravenous or intramuscular injection, sterile production is of paramount importance.

Partnering with a WHO-GMP certified manufacturer ensures that the sterile powder formulation meets strict quality control guidelines, including pyrogen testing and sterility validation. This provides consistent efficacy, minimal batch variation, and complete regulatory compliance for both domestic distribution and international export markets, satisfying the requirements of regional distributors and PCD franchise networks alike.